Arresto Biosciences
Latest round
- Series C
Last raised
- Apr 2010
Total raised
- $33M
Investors
- 3
About Arresto Biosciences
Arresto Biosciences, founded in 2007 and headquartered in Palo Alto, US, focuses on developing digital solutions for operational efficiency. The company was sold to Gilead Sciences in December 2010 for USD 225 mn. The founder has not been specified, and no previous company information is available.com offers a range of innovative digital solutions designed to enhance operational efficiency for businesses across various sectors. The company’s core product is a comprehensive software platform that integrates advanced analytics and real-time data processing capabilities, enabling clients to streamline their workflows and improve decision-making processes. These solutions serve end users in industries such as finance, healthcare, and logistics, addressing specific challenges such as data management, compliance, and operational transparency. The platform is particularly popular among medium to large enterprises that require robust, scalable solutions.com is primarily based on a subscription model, allowing clients to access its software services on a recurring basis. This model provides a steady revenue stream, as customers typically enter into annual contracts with various pricing tiers depending on their features and organization size.com also engages in partnerships with different industry stakeholders, thereby expanding its reach and enhancing service delivery. Clients may choose from different packages, catering to specific needs, such as basic access for smaller firms or comprehensive solutions for larger enterprises requiring advanced functionalities. The company plans to release these updates by the end of 2023. Additionally, Arresto is looking to expand its market presence in Asia and Europe, with targeted expansion by the end of 2024.
Who invested in Arresto Biosciences
3 investors across 3 rounds
See all investors in Arresto Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Arresto Biosciences
Who invested in Arresto Biosciences?
Arresto Biosciences has 3 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Arresto Biosciences raised?
Arresto Biosciences has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Arresto Biosciences last raise money?
Arresto Biosciences's most recent round on record is a Series C, in Apr 2010.
What does Arresto Biosciences do?
Arresto Biosciences, founded in 2007 and headquartered in Palo Alto, US, focuses on developing digital solutions for operational efficiency.
Where is Arresto Biosciences headquartered?
Arresto Biosciences is headquartered in Palo Alto, US.
Which VCs invest in companies like Arresto Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Arresto Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Arresto Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.